Moderna aims for fall release of COVID-19 Omicron vaccine
Global News
Before Omicron came along, Moderna was studying a combination shot that added protection against an earlier COVID-19 variant named Beta.
Moderna hopes to offer updated COVID-19 boosters in the fall that combine its original vaccine with protection against the Omicron variant. On Tuesday, it reported a preliminary hint that such an approach might work.
Today’s COVID-19 vaccines all are based on the original version of COVID-19. But the virus continues to mutate, with the super-contagious Omicron variant – and its siblings – the latest threat.
Before Omicron came along, Moderna was studying a combination shot that added protection against an earlier variant named Beta.
Tuesday, the company said people given that Beta-original vaccine combination produced more antibodies capable of fighting several variants – including Omicron – than today’s regular booster triggers.
While the antibody increase was modest, Moderna’s goal is to produce a combination shot that specifically targets Omicron.
“These results really give us hope” that next step will work even better, said Dr. Jacqueline Miller, a Moderna vice president.
Tuesday’s data was reported online and hasn’t been vetted by independent experts.
COVID-19 vaccines still are providing strong protection against severe disease, hospitalization and death, even against Omicron.
Many kids and teens are looking forward to the holidays with great excitement, but others find it a difficult time of year filled with anxiety, stress and loneliness. It’s something Alisa Simon, the chief youth officer at Kids Help Phone, says they watch for when school pauses for the winter break, noting, “we do see an increase...